Could Ozempic and Other GLP-1 Drugs Treat Alcohol Use Disorder
& PIONEER 4 Investigators
Indeed, once-weekly injections (for either 5 weeks or 9 weeks) of dulaglutide have been shown to reduce both alcohol consumption and preference for alcohol in male rats throughout the treatment period (Vallof et al., 2020)
This condition can lead to various pathological changes, including neuroinflammation, apoptosis of neurons, impaired BBB, synaptic plasticity deficiency, and mitochondrial dysfunction
While not a kidney-disease predictor, this test helps personalize your semaglutide or tirzepatide dose to optimize both weight loss and metabolic protection, including kidney function support
One of the main predictors of whether you are a viable candidate to need Semaglutide GLP-1 injections for weight loss is if you are considered obese, which is indicated by a body mass index of 30 or over